Prediction of survival and recurrence by serum and cytosolic levels of CEA, CA125 and SCC antigens in resectable non-small-cell lung cancer

被引:67
作者
Diez, M
Torres, A
Maestro, ML
Ortega, MD
Gomez, A
Pollan, M
Lopez, JA
Picardo, A
Hernando, F
Balibrea, JL
机构
[1] UNIV MADRID, SAN CARLOS HOSP, MADRID 3, SPAIN
[2] INST SALUD CARLOS 3, NATL CTR EPIDEMIOL, CANC EPIDEMIOL UNIT, MADRID, SPAIN
关键词
carcinoembryonic antigen; CA125; squamous cell carcinoma antigen; lung cancer; prognostic factor; survival;
D O I
10.1038/bjc.1996.239
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Risk of death and risk of recurrence in 108 potentially curable non-small-cell lung cancer patients were analysed with respect to TNM stage, histological type and carcinoembryonic antigen (CEA), CA125 antigen and squamous cell carcinoma antigen (SCC) levels in serum and cytosol. CA125 and CEA levels were closely related to outcome figures. Multivariate analyses indicated that TNM stage and histological type had the best predictive power. but serum and cytosolic CA125 and serum CEA contained additional, independent prognostic information. Predictive information drawn from serum and cytosolic levels proved mutually complementary. We conclude that CA125 and CEA complement TNM classification and histological type for the purpose of quantifying risk of death or recurrence.
引用
收藏
页码:1248 / 1254
页数:7
相关论文
共 27 条
  • [1] [Anonymous], 1981, HIST TYP LUNG TUM
  • [2] SURGICAL-TREATMENT OF LUNG-CANCER .2.
    BAINS, MS
    [J]. CHEST, 1991, 100 (03) : 826 - 837
  • [3] CLINICAL USEFULNESS OF SERUM ASSAYS OF NEURON-SPECIFIC ENOLASE, CARCINOEMBRYONIC ANTIGEN AND CA-50 ANTIGEN IN THE DIAGNOSIS OF LUNG-CANCER
    BERGMAN, B
    BREZICKA, FT
    ENGSTROM, CP
    LARSSON, S
    [J]. EUROPEAN JOURNAL OF CANCER, 1993, 29A (02) : 198 - 202
  • [4] LUNG-CANCER BIOLOGY
    CARNEY, DN
    [J]. EUROPEAN JOURNAL OF CANCER, 1991, 27 (03) : 366 - 369
  • [5] SQUAMOUS-CELL CARCINOMA ANTIGEN (SCC AG) IN THE DIAGNOSIS AND PROGNOSIS OF LUNG-CANCER
    DECOS, JS
    MASA, F
    DELACRUZ, JL
    DISDIER, C
    VERGARA, C
    [J]. CHEST, 1994, 105 (03) : 773 - 776
  • [6] DIEZ M, 1994, CANCER-AM CANCER SOC, V73, P1368, DOI 10.1002/1097-0142(19940301)73:5<1368::AID-CNCR2820730510>3.0.CO
  • [7] 2-O
  • [8] DIEZ M, 1994, J TUMOR MARKER ONCOL, V9, P25
  • [9] Diez M., 1995, International Journal of Biological Markers, V10, P5
  • [10] FIELDING LP, 1992, CANCER, V70, P2367, DOI 10.1002/1097-0142(19921101)70:9<2367::AID-CNCR2820700927>3.0.CO